Skip to main content
. Author manuscript; available in PMC: 2022 Dec 30.
Published in final edited form as: J Invest Dermatol. 2022 May;142(5):1243–1252.e1. doi: 10.1016/j.jid.2022.01.016

Table 1.

Optical Imaging Technologies for Noninvasive Optical Skin Biopsy: Key Parameters

Optical Imaging System/Key Parameters MultiBeam OCT (VivoSight) RCM (VivaScope) MPM (MPTflex)
Contrast Scattering Scattering TPEF/SHG
Lateral spatial resolution <7.5 μm ~1 μm <1 μm
Axial spatial resolution <5 μm <2 μm <2 μm
Imaging depth <2 μm <250 μm <250 μm
Imaging FOV 6 × 6 mm2 500 × 500 μm2 (single image) up to 8 × 8 mm2 (tiling)1 250 × 250 μm2 (single image)
Imaging time per unit area 0.02 s/mm2 0.5 s/mm2 96 s/mm2
Estimated total imaging time few seconds Tens of seconds to a few minutes 10–20 minutes
Key performance features Deep penetration Large FOV Subcellular resolution + large FOV Submicron resolution Molecular contrast
Limitations Low spatial resolution No molecular contrast No molecular contrast Limited FOV
Clinical value for skin imaging 3D macroscopic view of the lesion morphology Macroscopic view of the lesion morphology with subcellular resolution Selective visualization of the cellular and extracellular matrix with submicron resolution
Morphological features visualized in BCC, recurrent nevi, and melanoma BCC nests Overall 3D delineation of lesions BCC nests, dendritic and immune cells, melanocytes, and overall cellular and fibrillar structure Cellular-resolved BCC and nevus cell nests, dendritic and immune cells, melanocytes, and collagen and elastin fibers

Abbreviations: 3D, three-dimensional; BCC, basal cell carcinoma; CPT, Current Procedural Terminology; FOV, field ofview; MPM, multiphoton microscopy; OCT, optical coherence tomography; RCM, reflectance confocal microscopy; SHG, second harmonic generation; TPEF, two-photon excited fluorescence.

1

The handheld version of the RCM clinical device (VivaScope 3000) can scan a larger area, but it is not currently covered by the CPT I codes.